NATR

Business Context and Reporting Period

Company: Nature's Sunshine Products, Inc. (NATR)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended March 31, 2026
Business Overview: A global manufacturer and marketer of herbal and nutritional supplements sold through a direct sales network of independent consultants. The company operates in four geographic segments: Asia, Europe, North America, and Latin America & Other.

Key Financial Metrics

Cash Flow: Operating activities used $1.8 million in cash (compared to $2.6 million provided in Q1 2025), primarily due to timing of payments and changes in working capital. Investing activities used $2.5 million for capital expenditures. Financing activities used $1.6 million, including $0.5 million for share repurchases.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 8.5% year-over-year. Excluding foreign currency impacts, organic growth was 6.9%. The strengthening U.S. dollar contributed approximately $1.8 million to reported sales.
• Segment Performance:
  • Asia: Sales up 7.3% (5.9% organic). Driven by strong growth in China (+45.7%) and Japan (+12.9%), offset by a decline in Taiwan (-16.1%).
  • Europe: Sales up 9.5% (6.0% organic), driven by improved consumer acquisition.
  • North America: Sales up 9.4% (9.1% organic), supported by digital channel growth in the U.S.
  • Latin America & Other: Sales up 9.7% (5.6% organic).
• Profitability: Operating income increased 54.7% to $9.5 million. Gross margin improved to 73.2% due to cost savings initiatives and favorable market mix. SG&A expenses increased $3.0 million but decreased as a percentage of sales (35.4% vs 35.8%) due to reduced professional fees and marketing costs.
• Foreign Exchange: The company recorded a net foreign exchange loss of $1.4 million in Q1 2026, compared to a gain of $0.8 million in Q1 2025.
• Tax Rate: The effective tax rate increased to 37.2% from 31.3%, primarily due to the recording of a valuation allowance on foreign tax credits and the absence of favorable adjustments seen in the prior year.

Outlook, Risks, and Contingencies

• Guidance: The filing does not provide specific numerical guidance for the full year 2026. Management expects foreign currency fluctuations to continue impacting results and anticipates tariffs may adversely affect costs in the remainder of 2026.
• Regulatory & Legal:
  • Trade Controls: The company voluntarily disclosed potential trade control violations to the U.S. Department of Commerce (BIS) and OFAC. The BIS matter was closed without further action in November 2025; the OFAC matter remains pending. Management estimates violations represented less than 1% of net revenue and believes potential fines would not be material.
  • Eastern Europe: Ongoing conflict in Ukraine continues to impact operations, though sales in the region increased to $17.6 million in Q1 2026.
  • Contingencies: Accrued liabilities for legal proceedings are $0.9 million, with potential future payments estimated between $0 and $2.9 million. Non-income tax contingencies are accrued at $0.2 million, with potential exposure up to $3.8 million.
• China Operations: In December 2025, the company completed the purchase of Fosun Industrial's interests in its Chinese joint ventures, resulting in 100% ownership.
• Share Repurchases: The company repurchased 20,000 shares for $0.5 million in Q1 2026. $16.9 million remains available under the current repurchase program.

Investor Verification Checklist

• Foreign Exchange Sensitivity: Verify the impact of currency fluctuations on future earnings, as the company operates significantly outside the U.S.
• Regulatory Resolution: Monitor the status of the pending OFAC voluntary self-disclosure regarding trade control violations.
• Tax Provision Volatility: Review the sustainability of the 37.2% effective tax rate and the utilization of foreign tax credits.
• China Growth Sustainability: Assess whether the 45.7% sales growth in China is sustainable following the full acquisition of the joint ventures.
• Working Capital Trends: Investigate the shift from positive to negative operating cash flow, driven by changes in accrued liabilities and deferred revenue.